Barreiro EJ - Search Results

1

Synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agents.

Zapata-Sudo G, da Costa Nunes IK, Araujo JS, da Silva JS, Trachez MM, da Silva TF, da Costa FP, Sudo RT, Barreiro EJ, Lima LM. Zapata-Sudo G, et al. Among authors: barreiro ej. Drug Des Devel Ther. 2016 Sep 9;10:2869-2879. doi: 10.2147/DDDT.S108327. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27672310 Free PMC article.

2

Novel phthalimide derivatives, designed as leukotriene D(4) receptor antagonists.

Lima LM, de Brito FC, de Souza SD, Miranda AL, Rodrigues CR, Fraga CA, Barreiro EJ. Lima LM, et al. Among authors: barreiro ej. Bioorg Med Chem Lett. 2002 Jun 3;12(11):1533-5. doi: 10.1016/s0960-894x(02)00203-2. Bioorg Med Chem Lett. 2002. PMID: 12031336

3

Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues.

Lima LM, Castro P, Machado AL, Fraga CA, Lugnier C, de Moraes VL, Barreiro EJ. Lima LM, et al. Among authors: barreiro ej. Bioorg Med Chem. 2002 Sep;10(9):3067-73. doi: 10.1016/s0968-0896(02)00152-9. Bioorg Med Chem. 2002. PMID: 12110331

4

Thienylhydrazone derivative increases sarcoplasmic reticulum Ca2+ release in mammalian skeletal muscle.

Zapata-Sudo G, Sudo RT, Maronas PA, Silva GL, Moreira OR, Aguiar MI, Barreiro EJ. Zapata-Sudo G, et al. Among authors: barreiro ej. Eur J Pharmacol. 2003 May 30;470(1-2):79-85. doi: 10.1016/s0014-2999(03)01757-6. Eur J Pharmacol. 2003. PMID: 12787834

5

Bioisosterism: a useful strategy for molecular modification and drug design.

Lima LM, Barreiro EJ. Lima LM, et al. Among authors: barreiro ej. Curr Med Chem. 2005;12(1):23-49. doi: 10.2174/0929867053363540. Curr Med Chem. 2005. PMID: 15638729 Review. No abstract available.

6

LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model.

Alexandre-Moreira MS, Takiya CM, de Arruda LB, Pascarelli B, Gomes RN, Castro Faria Neto HC, Lima LM, Barreiro EJ. Alexandre-Moreira MS, et al. Among authors: barreiro ej. Int Immunopharmacol. 2005 Mar;5(3):485-94. doi: 10.1016/j.intimp.2004.10.017. Int Immunopharmacol. 2005. PMID: 15683845

7

Design, synthesis and antiinflammatory activity of novel phthalimide derivatives, structurally related to thalidomide.

Machado AL, Lima LM, Araújo JX Jr, Fraga CA, Koatz VL, Barreiro EJ. Machado AL, et al. Among authors: barreiro ej. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1169-72. doi: 10.1016/j.bmcl.2004.12.012. Bioorg Med Chem Lett. 2005. PMID: 15686935

8

Evaluating the prophylactic potential of the phtalimide derivative LASSBio 552 on allergen-evoked inflammation in rats.

Neves JS, Lima LM, Fraga CA, Barreiro EJ, Miranda AL, Diaz BL, Balduino A, Siqueira Rde A, e Silva PM, Martins MA. Neves JS, et al. Among authors: barreiro ej. Eur J Pharmacol. 2005 Mar 28;511(2-3):219-27. doi: 10.1016/j.ejphar.2005.02.011. Eur J Pharmacol. 2005. PMID: 15792791

9

Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues.

Silva AG, Zapata-Sudo G, Kummerle AE, Fraga CA, Barreiro EJ, Sudo RT. Silva AG, et al. Among authors: barreiro ej. Bioorg Med Chem. 2005 May 16;13(10):3431-7. doi: 10.1016/j.bmc.2005.03.003. Bioorg Med Chem. 2005. PMID: 15848755

10

Hydrolysis of new phthalimide-derived esters catalyzed by immobilized lipase.

Bevilaqua JV, Lima LM, Cunha AG, Barreiro EJ, Alves TL, Paiva LM, Freire DM. Bevilaqua JV, et al. Among authors: barreiro ej. Appl Biochem Biotechnol. 2005 Spring;121-124:117-28. doi: 10.1385/abab:121:1-3:0117. Appl Biochem Biotechnol. 2005. PMID: 15917593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page